Zealand Pharma A/S
ZLDPF
$61.52
-$6.48-9.53%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.29M | 650.60K | 4.92M | 2.20M | 3.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29M | 650.60K | 4.92M | 2.20M | 3.35M |
| Cost of Revenue | 58.30K | -975.50K | 1.37M | 669.30K | 1.70M |
| Gross Profit | 1.24M | 1.63M | 3.56M | 1.53M | 1.66M |
| SG&A Expenses | 22.01M | 13.82M | 11.66M | 10.98M | 9.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -448.30K | 462.30K | -- | -- | 7.70K |
| Total Operating Expenses | 57.91M | 52.14M | 43.55M | 39.45M | 38.36M |
| Operating Income | -56.61M | -51.49M | -38.62M | -37.25M | -35.01M |
| Income Before Tax | -41.67M | -39.46M | -42.43M | -33.49M | -38.30M |
| Income Tax Expenses | -82.00K | -202.60K | -189.90K | -196.90K | -82.30K |
| Earnings from Continuing Operations | -41.59M | -39.26M | -42.24M | -33.29M | -38.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.59M | -39.26M | -42.24M | -33.29M | -38.22M |
| EBIT | -56.61M | -51.49M | -38.62M | -37.25M | -35.01M |
| EBITDA | -56.24M | -50.58M | -37.65M | -73.30M | -34.77M |
| EPS Basic | -0.59 | -0.56 | -0.67 | -0.54 | -0.65 |
| Normalized Basic EPS | -0.38 | -0.38 | -0.44 | -0.69 | -0.40 |
| EPS Diluted | -0.59 | -0.56 | -0.67 | -0.54 | -0.65 |
| Normalized Diluted EPS | -0.38 | -0.38 | -0.44 | -0.69 | -0.40 |
| Average Basic Shares Outstanding | 70.74M | 70.66M | 62.69M | 61.63M | 58.37M |
| Average Diluted Shares Outstanding | 70.74M | 70.66M | 62.69M | 61.63M | 58.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
